The Need for Identification Cards in Immuno-Oncology 


Area of Science:

• Oncology Nursing
• Cancer Therapeutics
• Immunotherapy

Background:

• Oncology nurses traditionally manage surgery, chemotherapy, and radiation therapy.
• Immuno-oncologic (I-O) therapy represents a significant shift in cancer treatment approaches.
• The rapid emergence of I-O therapies necessitates an evaluation of current care models.

Purpose of the Study:

• To assess the evolving needs of patients undergoing immuno-oncologic therapy.
• To identify challenges and requirements for oncology nurses and healthcare providers administering I-O therapies.
• To inform future nursing practice and educational strategies in the context of I-O cancer care.

Main Methods:

• Convened an I-O think tank at the Oncology Nursing Society (ONS) on March 28, 2017.
• Gathered 17 oncology nurse experts from across the United States.
• Included 7 ONS staff members in the expert discussion.

Main Results:

• Discussed the unique challenges faced by patients receiving I-O therapies.
• Identified specific needs for nurses administering and coordinating I-O treatments.
• Appraised the current landscape of I-O cancer care from a nursing perspective.

Conclusions:

• Immuno-oncologic therapies require specialized nursing knowledge and patient support.
• Oncology nurses play a crucial role in navigating the complexities of I-O treatment.
• Further development of resources and education is essential for optimal I-O patient care.